超早产儿救治已列入我国围产医学新的重点工作内容,其中<24周出生的生存极限早产儿(PEPI)的救治更是其中的难点。迄今,全球尚无PEPI救治相关指南,各国家/地区PEPI的存活率和救治质量存在较大差异。2024年底,中国医师协会新生儿科医师分会、中国中西医结合学会围产医学专业委员会发布了《生存极限早产儿早期救治管理方案(建议)》,本文针对该建议的主要内容予以简要解读。
超早产儿救治已列入我国围产医学新的重点工作内容,其中<24周出生的生存极限早产儿(PEPI)的救治更是其中的难点。迄今,全球尚无PEPI救治相关指南,各国家/地区PEPI的存活率和救治质量存在较大差异。2024年底,中国医师协会新生儿科医师分会、中国中西医结合学会围产医学专业委员会发布了《生存极限早产儿早期救治管理方案(建议)》,本文针对该建议的主要内容予以简要解读。
The treatment of extremely preterm infants has been included as a new key focus in China's perinatal medicine, with the treatment of periviable extremely preterm infants (PEPI) born at <24 weeks of gestation posing a particularly prominent challenge. To date, there is no relevant global guideline for the treatment of PEPI, and significant disparities exist in PEPI survival rates and quality of treatment across different countries/regions. At the end of 2024, the Neonatologist Branch of the Chinese Medical Doctor Association and the Perinatal Medicine Committee of the Chinese Association of Integrative Medicine jointly released the Management Plan for Early Treatment of Periviable Extremely Preterm Infants (Recommendations). This paper provides a brief interpretation of the key contents of this recommendations.